Copyright
©2011 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Nov 7, 2011; 17(41): 4640-4642
Published online Nov 7, 2011. doi: 10.3748/wjg.v17.i41.4640
Published online Nov 7, 2011. doi: 10.3748/wjg.v17.i41.4640
Pancreatic cancer risk variant ABO rs505922 in patients with cholangiocarcinoma
Marcin Krawczyk, Florentina Mihalache, Frank Lammert, Vincent Zimmer, Department of Medicine II, Saarland University Medical Center, 66421 Homburg, Germany
Florentina Mihalache, Monica Acalovschi, Department of Medicine III, University Iuliu Hatieganu, 400162 Cluj-Napoca, Romania
Aksana Höblinger, Department of Internal Medicine I, University Hospital Bonn, 53127 Bonn, Germany
Author contributions: Krawczyk M and Mihalache F contributed equally to this work; Mihalache F performed genotyping; Mihalache F, Höblinger A, Acalovschi M and Zimmer V included patients and controls in the study; Krawczyk M, Lammert F and Zimmer V analyzed the data; Zimmer V and FLammert F designed and supervised the project; Krawczyk M, Zimmer V and Lammert F wrote and edited the paper.
Correspondence to: Dr. Marcin Krawczyk, Department of Medicine II, Saarland University Medical Center, Kirrberger Str. 1, 66421 Homburg, Germany. marcin.krawczyk@uks.eu
Telephone: +49-6841-1623242 Fax: +49-6841-1623570
Received: January 9, 2011
Revised: June 21, 2011
Accepted: June 28, 2011
Published online: November 7, 2011
Revised: June 21, 2011
Accepted: June 28, 2011
Published online: November 7, 2011
Core Tip